• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Chemother . Epidemiology of endemic human coronavirus infection during the COVID-19 pandemic

tetano

Editor, Senior Moderator
J Infect Chemother


. 2023 Nov 16:S1341-321X(23)00284-2.
doi: 10.1016/j.jiac.2023.11.012. Online ahead of print. Epidemiology of endemic human coronavirus infection during the COVID-19 pandemic

Fujio Kakuya[SUP] 1 [/SUP], Ryuta Terao[SUP] 2 [/SUP], Hikaru Onoda[SUP] 2 [/SUP], Hitoshi Okubo[SUP] 2 [/SUP], Hiroaki Fujiyasu[SUP] 2 [/SUP], Fumie Inyaku[SUP] 2 [/SUP], Ai Fukuura[SUP] 3 [/SUP], Toshio Arai[SUP] 3 [/SUP], Takahiro Kinebuchi[SUP] 4 [/SUP]



Affiliations
Abstract

Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a member of the coronavirus family that also includes endemic human coronaviruses (HCoVs) types OC43, HKU1, 229E, and NL63. HCoVs share extensive sequence homology with SARS-CoV-2. It has been assumed that HCoV infection occur primarily in winter and spring in Japan before the coronavirus disease 2019 (COVID-19) pandemic and that its frequency is the same for all age groups.
Methods: Nasopharyngeal swab samples were collected for HCoVs and SARS-CoV-2. All medical data were retrospectively analyzed. Our primary objective was to describe the epidemiology of HCoV in the Furano, Japan during the COVID-19 pandemic. Our secondary objective was to compare the prevalence of HCoV with that of SARS-CoV-2.
Results: From September 2020 to August 2022, 113 (6.2 %) of 1823 cases were positive for any HCoV. The HCoV-NL63 activity peaked in January-March 2021. The HCoV-OC43 activity peaked in June-August 2021. HCoVs were mostly detected at age ≤11 years and most frequently at age ≤2 years. HCoVs showed high detection in 2021, while SARS-CoV-2 showed moderate detection in 2020-2021, but significantly increased in 2022.
Conclusions: During the COVID-19 pandemic, HCoV-OC43 activity peaked in the summer. The frequency of HCoV infection varied widely by age group and was higher among those aged ≤11 years. These were different from those reported before the COVID-19 pandemic. These findings suggest that the disease dynamics of HCoVs remain unclear and that continued surveillance is essential in the post-COVID-19 pandemic.

Keywords: COVID-19; Endemic human coronavirus; Epidemiology; Pandemic; SARS-CoV-2.

 
Back
Top